Skip to content

Author

Federica Barbieri

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Repurposing Triamterene as Chloride Intracellular Channel 1 Inhibitor via Ligand-Based Approach: A Novel Adjuvant Treatment for Glioblastoma.

Triamterene emerges as a repurposed anti-glioblastoma agent with higher potency and tumor selectivity than metformin, together with its well-known favorable pharmacokinetic profile, which makes TMT a promising candidate for clinical translation in glioblastoma patients.

Federica Barbieri, F. Cianci, B. Tremonti et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.